Brand In Focus | AliveCor 


Tech driven brand AliveCor is bringing heart data at the fingertips of patients and professionals to upend heart treatment, management and outcomes. 



AliveCor is a leading player in AI-based personal ECG technology, transforming cardiological care using deep learning. The company is credited with the most clinically validated personal ECG solution in the world. 

Brand AliveCor is the leading FDA-cleared mobile heart solution that delivers intelligent, highly personalized information about the heart to clinicians and patients anytime, anywhere. Its offering - KardiaMobile device - is the most clinically validated personal ECG solution in the world and the KardiaMobile 6L is the only FDA cleared 6L device. 

AliveCor is committed to innovating digital health services in India by offering patients the ability to take control of their own heart health from the comfort of home.

Detailed information on the brand is available at



“AliveCor, Inc. is transforming cardiological care using deep learning. KardiaMobile provides instant detection of atrial fibrillation, bradycardia, tachycardia, and normal heart rhythm in an ECG. Kardia is the first AI-enabled platform to aid patients and clinicians in the early detection of atrial fibrillation, the most common arrhythmia and one associated with a highly elevated risk of stroke. AliveCor’s enterprise platform allows third party providers to manage their patients and customers’ heart conditions simply and profitably using state-of-the-art tools that provide easy front-end and back-end integration to AliveCor technologies”, says  Priya Abani, Chief Executive Officer, Alivecor, capturing the essence of the brand in short. 



The company was co-founded by Dr. David Albert, a medical doctor and former chief clinical scientist of cardiology at General Electric, along with scientists Bruce Satchwell and Kim Barnett. Dr. David started working on ECGs for handheld computers in 1990, when the first palm top computer was released by Hewlett-Packard. He received a 1998 patent for wireless transmission of ECGs in handheld devices. In December 2010, Albert demonstrated a prototype of an iPhone ECG through a YouTube video and that was the start of the journey to develop a US-FDA approved, most clinically validated personal ECG solution in the world. 



With hundreds of millions at risk from heart disease across the globe, accessible heart care has never been more important. India has been witnessing rapid increase in cardiovascular diseases amongst its population, with the number of cases doubling from 1990 to 2016. There are millions of people at risk from heart disease in India, and with the ongoing pandemic and stay-at-home orders in place, many people find it hard to get even the routine healthcare they need for fear of increasing their risk of exposure to COVID-19. 

KardiaMobile’s launch in India has not only made it easier for people to stay on top of their heart health from home. Indeed, the innovation has been optimizing precious time, money and resources for multiple stakeholders in India’s healthcare ecosystem. The portable and technology-enabled ECG device can help deliver affordable and convenient heart care to millions heart patients and those at risk, without visiting a hospital. 



AliveCor’s technology gives patients the ability to record a medical-grade ECG in just 30 seconds, with no hospital visits and complete peace of mind. 

The device is small enough to fit in a pocket, allowing users to check in on their heart anytime, anywhere right from their smartphone. 


BRAND DNA : Vision – mission – philosophy

Brand AliveCor’s mission is to save lives and transform the cardiology terrain by delivering intelligent and highly personalized heart data to clinicians and patients anytime and anywhere.

The brand’s vision is to be the ‘Go-To’ 24X7 virtual cardiologist for patients when they’re not in front of their physician.



Priya Abani, Chief Executive Officer 

David E. Albert, Chief Medical Officer 

Ira Bahr, Chief Commercialization Officer

Lokesh Prasad, Managing Director, India 



AliveCor has recently acquired the independent diagnostic testing facility (IDTF) Cardio Labs, a leading monitoring and cardiac diagnostic service provider in USA. The acquisition is a cornerstone of AliveCor's mission to extend a comprehensive suite of cardiological services to patients who are prescribed monitoring devices by their healthcare providers.

AliveCor has also teamed up with Medanta, a leading provider of enterprise healthcare solutions, to bring in the world’s first program to reimagine ‘Heart Health’ in India. This partnership would mean that an individual can get access to the medical expertise of a Medanta cardiologist who will monitor heart health 24X7 through the technological expertise of AliveCor’s US-FDA approved wireless ECG-reading device KardiaMobile 6L. Each patient will become more empowered (‘atmanirbhar’) to take care of their heart health through this first-of-a-kind collaboration, reducing stress and anxiety for millions of Indians at risk of cardiovascular disease. This partnership promises the ease of flexibility with a wireless, patch-less service with 24X7 monitoring and access to world-class Cardiologists. 


FEATHERS IN THE CAP: Honours and Awards

AliveCor has received multiple awards since the company since inception, such as…

1) Mention on Fast Company's Most Innovative Top 50 Artificial Intelligence list

2) Prevention Magazine's Health Breakthrough Award for KardiaMobile 6L 

3) Rock Health Top 50 in Digital Health award, among others.



"With hundreds of millions at risk for heart disease across the globe, accessible heart care has never been more important. AliveCor's expansion into India is pivotal to our mission of providing remote, medical-grade heart care to those who need it most. We are committed to innovating digital health services in India by offering patients the ability to take control of their own heart health from the comfort of home”. 

- Priya Abani, Chief Executive Officer, AliveCor.


*This story is published by VOH team*


Partners & Associate